Adrenal insufficiency
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayeesha Kattubadi, M.B.B.S[2] Muhammad Saad, M.B.B.S.[3]
Synonyms and keywords: Addison’s disease
Overview
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayeesha Kattubadi, M.B.B.S[2] Muhammad Saad, M.B.B.S.[3]
Overview
Adrenal insufficiency is a clinical state where there is reduced production of adrenocortical hormones. The adrenal cortex is divided into three zones- zona glomerulosa, zona fasciculata and zona reticularis producing mineralocorticoids, glucocorticoids and androgens respectively. Adrenal insufficiency causes glucocorticoid and mineralocorticoid deficiency. It is classified as primary, secondary and glucocorticoid induced adrenal insufficiency. Its presentation depends on the rapidity and degree of hormone depletion. It can present acutely as adrenal crisis, especially when the body is under stress due infections, trauma etc. If it presents chronically it is called Addisons disease. Treatment consists of lifelong glucocorticoid and mineralocorticoid replacement.
Historical Perspective
Adrenal insufficiency was first discovered by Thomas Addison in 1849. [1]
Classification
Adrenal insufficiency may be classified according to location of pathology into three subtypes primary adrenal insufficiency, secondary adrenal insufficiency, and glucocorticoid induced adrenal insufficiency. [2]
Pathophysiology
It is thought that adrenal insufficiency is the result of multiple etiologies like autoimmune adrenalitis, X-linked adrenoleukodystrophy, chronic glucocorticoid use, adrenal hemoorage etc. The pathophysiology depends on each etiological subtype. [3] [4][5] [6][7] [8]
Causes
Common causes of adrenal insufficiency include autoimmune adrenalitis and chronic glucocorticoid use. [2] [9]
Differentiating adrenal insufficiency from Other Diseases
Addison’s disease must be differentiated from other diseases that cause hypotension, skin pigmentation, and abdominal pain such as myopathies, celiac disease, Peutz-Jeghers syndrome, anorexia nervosa, syndrome of inappropriate antidiuretic hormone (SIADH), neurofibromatosis, porphyria cutanea tarda, salt-depletion nephritis and bronchogenic carcinoma.
Epidemiology and Demographics
Adrenal insufficiency is a rare disorder. It may present in patients of all age groups. The incidence of autoimmune adrenalitis is more common in females in the age groups of 30 to 50 compared to males. Whereas, adrenal crisis does not show any female to male predilection. The most common cause of primary adrenal insufficiency in the developed world is autoimmune adrenalitis. Whereas, in the developing world it is Tuberculosis. The most common cause of central adrenal insufficiency is chronic glucocorticoid use. [10] [11]
Risk Factors
Common risk factors in the development of adrenal insufficiency include chronic glucocorticoid use, tuberculosis, anticoagulant use, etc. [12].
Screening
There is insufficient evidence to recommend routine screening for adrenal insufficiency. [13]
Natural History, Complications, and Prognosis
Common complications of adrenal insufficiency include cardiovascular complications, disturbed sleep, reduced bone mineral density. Prognosis is generally excellent with replacement therapy. [14][4]
Diagnosis
Diagnostic Study of Choice
The ACTH stimulation test is considered the diagnostic test of choice.
History and Symptoms
The hallmark of adrenal insufficiency is fatigue. Most patients with adrenal insufficiency present with non specific symptoms. A positive history of fatigue,nausea and abdominal pain is suggestive of adrenal insufficiency. The most common symptoms of adrenal insufficiency include fatigue, anorexia, and weight loss. Common symptoms of adrenal insufficiency include abdominal pain, nausea, and vomiting. Less common symptoms of adrenal insufficiency include diarrhea, arthralgia, and myalgia. [15][13]
Physical Examination
Patients with adrenal insufficiency usually appear dehydrated and weak. Physical examination of patients with primary adrenal insufficiency is usually remarkable for hyperpigmentation of skin. [15][16]
Laboratory Findings
Laboratory findings consistent with the diagnosis of primary adrenal insufficiency include hyponatremia, hyperkalemia, and hypercalcemia, normocytic normochromic anemia, eosinophilia.[13]
Electrocardiogram
ECG findings seen in adrenal insufficiency are due to hyperkalemia. These changes include peaked T waves, short QT interval, prolonged PR interval, loss of P wave, widened QRS complex. [17]
X-ray
X-ray may be helpful in the diagnosis of etiology of adrenal insufficiency, which include tuberculosis, sarcoidosis. [2]
Echocardiography and Ultrasound
There are no echocardiography findings associated with adrenal insufficiency. However, an echocardiography may be helpful in the diagnosis of cardiovascular complications of adrenal insufficiency, which include ischemic heart disease, heart failure, and dilated cardiomyopathy. [18]
CT scan
CT scan may be helpful in the diagnosis of etiology of adrenal insufficiency, which include adrenal hemorrhage, tuberculous adrenalitis, and adrenal metastasis.[2]
MRI
A pituitary MRI may be helpful in the diagnosis of secondary adrenal insufficiency[2].
Treatment
Medical Therapy
Pharmacologic medical therapy is recommended among patients with adrenal insufficiency Pharmacologic medical therapies for adrenal insufficiency include lifelong glucocorticoid and mineralocorticoid replacement therapy. Mineralocorticoid replacement therapy is only used in patients with primary adrenal insufficiency. [9] [19][20]
Surgery
Surgical intervention is not recommended for the management of adrenal insufficiency. [21]
Primary Prevention
There are no established measures for the primary prevention of adrenal insufficiency. [22]
Secondary Prevention
There are no established measures for the secondary prevention of adrenal insufficiency.
References
- ↑ BISHOP PM (1950). “The history of the discovery of Addison’s disease”. Proc R Soc Med. 43 (1): 35–42. PMC 2081266. PMID 15409948.
- ↑ 2.0 2.1 2.2 2.3 2.4 Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dungan K; et al. (2000). “Endotext”. PMID 25905309.
- ↑ “StatPearls”. 2020. PMID 28722862.
- ↑ 4.0 4.1 Erichsen, Martina M.; Løvås, Kristian; Skinningsrud, Beate; Wolff, Anette B.; Undlien, Dag E.; Svartberg, Johan; Fougner, Kristian J.; Berg, Tore J.; Bollerslev, Jens; Mella, Bjarne; Carlson, Joyce A.; Erlich, Henry; Husebye, Eystein S. (2009). “Clinical, Immunological, and Genetic Features of Autoimmune Primary Adrenal Insufficiency: Observations from a Norwegian Registry”. The Journal of Clinical Endocrinology & Metabolism. 94 (12): 4882–4890. doi:10.1210/jc.2009-1368. ISSN 0021-972X.
- ↑ Huffnagel, Irene C; Laheji, Fiza K; Aziz-Bose, Razina; Tritos, Nicholas A; Marino, Rose; Linthorst, Gabor E; Kemp, Stephan; Engelen, Marc; Eichler, Florian (2019). “The Natural History of Adrenal Insufficiency in X-Linked Adrenoleukodystrophy: An International Collaboration”. The Journal of Clinical Endocrinology & Metabolism. 104 (1): 118–126. doi:10.1210/jc.2018-01307. ISSN 0021-972X.
- ↑ Berger J, Forss-Petter S, Eichler FS (2014). “Pathophysiology of X-linked adrenoleukodystrophy”. Biochimie. 98: 135–42. doi:10.1016/j.biochi.2013.11.023. PMC 3988840. PMID 24316281.
- ↑ Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dungan K; et al. (2000). “Endotext”. PMID 25905379.
- ↑ Younes, Areej K.; Younes, Noor K. (2017). “Recovery of steroid induced adrenal insufficiency”. Translational Pediatrics. 6 (4): 269–273. doi:10.21037/tp.2017.10.01. ISSN 2224-4336.
- ↑ 9.0 9.1 Bornstein, Stefan R.; Allolio, Bruno; Arlt, Wiebke; Barthel, Andreas; Don-Wauchope, Andrew; Hammer, Gary D.; Husebye, Eystein S.; Merke, Deborah P.; Murad, M. Hassan; Stratakis, Constantine A.; Torpy, David J. (2016). “Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline”. The Journal of Clinical Endocrinology & Metabolism. 101 (2): 364–389. doi:10.1210/jc.2015-1710. ISSN 0021-972X.
- ↑ Melmed, Shlomo (2020). Williams textbook of endocrinology. Philadelphia, PA: Elsevier. ISBN 9780323555968.
- ↑ Elshimy G, Alghoula F, Jeong JM. PMID 29763143. Missing or empty
|title=(help) - ↑ “www.amjmed.com”.
- ↑ 13.0 13.1 13.2 Chanson, Philippe; Guignat, Laurence; Goichot, Bernard; Chabre, Olivier; Boustani, Dinane Samara; Reynaud, Rachel; Simon, Dominique; Tabarin, Antoine; Gruson, Damien; Reznik, Yves; Raffin Sanson, Marie-Laure (2017). “Group 2: Adrenal insufficiency: screening methods and confirmation of diagnosis”. Annales d’Endocrinologie. 78 (6): 495–511. doi:10.1016/j.ando.2017.10.005. ISSN 0003-4266.
- ↑ “www.amjmed.com”.
- ↑ 15.0 15.1 Pazderska, Agnieszka; Pearce, Simon HS (2017). “Adrenal insufficiency – recognition and management”. Clinical Medicine. 17 (3): 258–262. doi:10.7861/clinmedicine.17-3-258. ISSN 1470-2118.
- ↑ Lause M, Kamboj A, Fernandez Faith E (2017). “Dermatologic manifestations of endocrine disorders”. Transl Pediatr. 6 (4): 300–312. doi:10.21037/tp.2017.09.08. PMC 5682371. PMID 29184811.
- ↑ Levis, Joel (2013). “ECG Diagnosis: Hyperkalemia”. The Permanente Journal. 17 (1): 69–69. doi:10.7812/TPP/12-088. ISSN 1552-5767.
- ↑ Rahvar, Amir-Hossein; Haas, Christian S.; Danneberg, Sven; Harbeck, Birgit (2017). “Increased Cardiovascular Risk in Patients with Adrenal Insufficiency: A Short Review”. BioMed Research International. 2017: 1–5. doi:10.1155/2017/3691913. ISSN 2314-6133.
- ↑ Oprea, Alina; Bonnet, Nicolas C. G.; Pollé, Olivier; Lysy, Philippe A. (2019). “Novel insights into glucocorticoid replacement therapy for pediatric and adult adrenal insufficiency”. Therapeutic Advances in Endocrinology and Metabolism. 10: 204201881882129. doi:10.1177/2042018818821294. ISSN 2042-0188.
- ↑ https://www.elsevier.es/index.php?p=revista&pRevista=pdf-simple&pii=S2173509314700698
- ↑ https://www.elsevier.es/index.php?p=revista&pRevista=pdf-simple&pii=S2173509314700698
- ↑ Dineen, Rosemary; Thompson, Christopher J; Sherlock, Mark (2019). “Adrenal crisis: prevention and management in adult patients”. Therapeutic Advances in Endocrinology and Metabolism. 10: 204201881984821. doi:10.1177/2042018819848218. ISSN 2042-0188.
Historical Perspective
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayeesha Kattubadi, M.B.B.S[2]
Overview
Adrenal insufficiency was first discovered by Thomas Addison in 1849.
Historical Perspective
Discovery
- Adrenal insufficiency was first discovered by Thomas Addison, a British physician and scientist, on 15 March, 1849. [1]
Landmark Events in the Development of Treatment Strategies
In 1950 Kendall, Richestein, Hench received Nobel Prize in Physiology and Medicine for their discovery of hormones of the adrenal cortex, their structure and biological effects. Following this steroids were used in the treatment of adrenal insufficiency. [2]
Famous Cases
The following are a few famous cases of adrenal insufficiency:
References
- ↑ BISHOP PM (1950). “The history of the discovery of Addison’s disease”. Proc R Soc Med. 43 (1): 35–42. PMC 2081266. PMID 15409948.
- ↑ https://www.nobelprize.org/prizes/medicine/1950/summary/
- ↑ https://en.wikipedia.org/wiki/John_F._Kennedy
- ↑ https://en.wikipedia.org/wiki/Jane_Austen
Classification
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayeesha Kattubadi, M.B.B.S[2] Muhammad Saad, M.B.B.S.[3]
Overview
Adrenal insufficiency may be classified according to location of pathology into three subtypes primary adrenal insufficiency, secondary adrenal insufficiency, and glucocorticoid-induced adrenal insufficiency.[1]
Classification
Adrenal Insufficiency may be classified according to location of pathology into three subtypes:
- Primary adrenal insufficiency
- Secondary adrenal insufficiency
- Glucocorticoid-induced adrenal insufficiency
Primary adrenal insufficiency:
In Primary adrenal insufficiency, the primary pathology lies in the adrenal glands leading to decreased production of cortisol, aldosterone and androgens. Although, the androgen deficiency manifests only in females as the adrenal gland is the only source of androgens in females.
Secondary adrenal insufficiency:
In Secondary adrenal insufficiency the pathology lies in the pituitary gland leading to reduced production of ACTH which is characterized by decreased cortisol and androgens production with preserved aldosterone secretion.[2]
Glucocorticoid-induced adrenal insufficiency:
Sometimes also known as tertiary adrenal insufficiency, glucocorticoid-induced adrenal insufficiency results from suppression of hypothalamic-pituitary-adrenal axis and is characterized by decreased production of cortisol and androgens with preserved aldosterone secretion.[1] It is the most common type of adrenal insufficiency .[3]Glucocorticoid induced adrenal insufficiency is the preferred term for adrenal insufficiency resulting from glucocorticoid use.[3]
References
- ↑ 1.0 1.1 “Adrenal Insufficiency in Adults: A Review | Endocrinology | JAMA | JAMA Network”.
- ↑ Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dungan K; et al. (2000). “Endotext”. PMID 25905309.
- ↑ 3.0 3.1 Beuschlein F, Else T, Bancos I, Hahner S, Hamidi O, van Hulsteijn L, Husebye ES, Karavitaki N, Prete A, Vaidya A, Yedinak C, Dekkers OM (May 2024). “European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and therapy of glucocorticoid-induced adrenal insufficiency”. Eur J Endocrinol. 190 (5): G25–G51. doi:10.1093/ejendo/lvae029. PMID 38714321 Check
|pmid=value (help).
Pathophysiology
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayeesha Kattubadi, M.B.B.S[2]
Overview
It is thought that adrenal insufficiency is the result of multiple etiologies like autoimmune adrenalitis, X-linked adrenoleukodystrophy, chronic glucocorticoid use, adrenal hemoorage etc. The pathophysiology depends on each etiological subtype.
Pathophysiology
Physiology
Adrenal insufficiency arises due to the deficiency of adrenocortical hormones.The normal physiology of adrenocortical hormone production can be understood as follows:The adrenal cortex is divided into three zones from outside to inside as – Zona glomerulosa, zona fasciculata and zona reticularis which are responsible for the production of streroid hormones like mineralocorticoid, glucocorticoid and androgens respectively. [1] Hypothalamus produces corticotropin-releasing hormone(CRH) which induces the pituitary to secrete ACTH also known as corticotropin. ACTH then stimulates the adrenal glands to produce mineralocorticoids and glucocorticoids.
Pathogenesis
The pathophysiology of adrenal insufficiency depends on the etiological subtype.
Autoimmune adrenalitis: Both humoral and cell-mediated immune mechanisms attack enzymes involved in adrenocortical hormone synthesis. Autoantibodies against 21-hydroxylase, an enzyme required in the biosynthesis of adrenocortical hormones can be found. The patients remain asymptomatic until 90% of the cortex is destroyed. It can present as isolated autoimmune adrenalitis in 30-40% of cases or as an autoimmune polyglandular syndrome in 60-70% of cases. The autoimmune polyglandular syndrome is subclassified as autoimmune polyglandular syndrome type 1(APS type 1) and autoimmune polyglandular syndrome type 2 (APS type 2) [2] [3]
X-linked Adrenoleukodystrophy(X-ALD): X-ALD occurs due to mutations in the peroxisomal ATP-binding cassette (ABC) transporter encoded by the ABCD1 gene. Disruption of this transport protein leads to the accumulation of Very Long Chain Fatty Acids (VLCFA). Male patients usually present in childhood or adolescence, whereas heterozygous females present between 40-50 years. The lifetime prevalence of adrenal insufficiency is 80% in males, with the highest risk being in the first decade. Adrenal Insufficiency is extremely rare in females. [4] [5]
Chronic glucocorticoid use: Chronic use of glucocorticoids can cause secondary or tertiary adrenal insufficiency and is the most common cause of adrenal insufficiency. Exogenous glucocorticoid use causes feedback inhibition of the HPA axis leading to reduced synthesis of CRH and ACTH by the hypothalamus and pituitary. As a consequence of reduced ACTH, the adrenal cortex slowly loses the ability to synthesize cortisol. The mineralocorticoid synthetic function of the adrenal cortex is retained as it depends on RAAS. HPA axis is usually suppressed when glucocorticoids were used for >2weeks. In some cases, the HPA axis may remain suppressed for as long as 6-12 months after glucocorticoid withdrawal. HPA axis can be suppressed with oral, inhaled, topical, injectable, intraarticular, intradermal, paraspinal, or rectal glucocorticoid preparations. [6] [7]
Genetics
Autoimmune adrenalitis: Genes involved in the pathogenesis of autoimmune adrenalitis include HLA DR3/DQ2 and DR4/DQ8.
- The autoimmune polyglandular syndrome type 1 is transmitted in an autosomal recessive pattern. Gene involved in the pathogenesis is the autoimmune regulator gene (AIRE).
- The autoimmune polyglandular syndrome type 2 shows a polygenic inheritance. A strong association has been shown with HLA DR3 of MHC.
X-linked adrenoleukodystrophy: Genes involved in the pathogenesis of X-ALD include the ABCD1 gene which causes an alteration in peroxisomal ATP-binding cassette (ABC) transporter.
Associated Conditions
- Autoimmune polyglandular syndrome type 1 is also known as Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED). It is associated with chronic mucocutaneous candidiasis, hyperparathyroidism, total alopecia.
- Autoimmune polyglandular syndrome type 2 is associated with autoimmune thyroiditis, vitiligo, premature ovarian failure, type 1 diabetes mellitus, pernicious anemia.
X-linked Adrenoleukodystrophy: Apart from presenting as adrenal insufficiency it is also associated with cerebral inflammatory demyelination, myelopathy.
Gross Pathology
On gross pathology, the adrenal gland is atrophied in autoimmune adrenalitis. Autopsy findings show a decrease in the size and weight of the gland. In addition there may be hyperpigmentation of the gland. [8]
Microscopic Pathology
On microscopic histopathological analysis, infiltration of the adrenal cortex with chronic inflammatory cells like lymphocytes is a characteristic finding in autoimmune adrenalitis. The adrenal cortex can be atrophied with the preservation of the medulla. [8]
References
- ↑ “StatPearls”. 2020. PMID 30725945.
- ↑ “StatPearls”. 2020. PMID 28722862.
- ↑ Erichsen, Martina M.; Løvås, Kristian; Skinningsrud, Beate; Wolff, Anette B.; Undlien, Dag E.; Svartberg, Johan; Fougner, Kristian J.; Berg, Tore J.; Bollerslev, Jens; Mella, Bjarne; Carlson, Joyce A.; Erlich, Henry; Husebye, Eystein S. (2009). “Clinical, Immunological, and Genetic Features of Autoimmune Primary Adrenal Insufficiency: Observations from a Norwegian Registry”. The Journal of Clinical Endocrinology & Metabolism. 94 (12): 4882–4890. doi:10.1210/jc.2009-1368. ISSN 0021-972X.
- ↑ Huffnagel, Irene C; Laheji, Fiza K; Aziz-Bose, Razina; Tritos, Nicholas A; Marino, Rose; Linthorst, Gabor E; Kemp, Stephan; Engelen, Marc; Eichler, Florian (2019). “The Natural History of Adrenal Insufficiency in X-Linked Adrenoleukodystrophy: An International Collaboration”. The Journal of Clinical Endocrinology & Metabolism. 104 (1): 118–126. doi:10.1210/jc.2018-01307. ISSN 0021-972X.
- ↑ Berger J, Forss-Petter S, Eichler FS (2014). “Pathophysiology of X-linked adrenoleukodystrophy”. Biochimie. 98: 135–42. doi:10.1016/j.biochi.2013.11.023. PMC 3988840. PMID 24316281.
- ↑ Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dungan K; et al. (2000). “Endotext”. PMID 25905379.
- ↑ Younes, Areej K.; Younes, Noor K. (2017). “Recovery of steroid induced adrenal insufficiency”. Translational Pediatrics. 6 (4): 269–273. doi:10.21037/tp.2017.10.01. ISSN 2224-4336.
- ↑ 8.0 8.1 Kemp WL, Koponen MA, Meyers SE (2016). “Addison Disease: The First Presentation of the Condition May be at Autopsy”. Acad Forensic Pathol. 6 (2): 249–257. doi:10.23907/2016.026. PMC 6506997 Check
|pmc=value (help). PMID 31239896.
Differential diagnosis
Please help WikiDoc by adding more content here. It’s easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Differentiating Adrenal insufficiency from other Diseases
Addison’s disease differential diagnosis
References
Epidemiology and Demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayeesha Kattubadi, M.B.B.S[2] Muhammad Saad, M.B.B.S.[3]
Overview
Adrenal insufficiency is a rare disorder. It may present in patients of all age groups. The incidence of autoimmune adrenalitis is more common in females in the age groups of 30 to 50 compared to males. Whereas, adrenal crisis does not show any female to male predilection. The most common cause of primary adrenal insufficiency in the developed world is autoimmune adrenalitis. Whereas, in the developing world it is Tuberculosis. The most common cause of central adrenal insufficiency is chronic glucocorticoid use.
Epidemiology and Demographics
Incidence
- The incidence of adrenal insufficiency is approximately 0.8 new cases per 100,000 individuals per year individuals in the developed world. [1]
- The incidence of adrenal insufficiency in Europe is approximately 4.4 to 6.2 new cases per 100,000 individuals per year .[2]
Prevalence
- The prevalence of primary adrenal insufficiency is approximately 117 to 221 cases per 1 million in European populations.[3] [4] [5] [6]
- The prevalence of secondary adrenal insufficiency is rare, ranging from 140 to 279 per 1 million individuals .[7] [8] [9]
Case-fatality rate/Mortality rate
- The mortality rate of adrenal crisis is approximately 0.5/100 patients/year. [10]
Age
- Patients of all age groups may develop adrenal insufficiency.
- Primary adrenal insufficiency commonly affects individuals between 20 to 50 years of age.[11]
- Secondary adrenal insufficiency commonly affects individuals in the 60s. [12]
- The incidence of adrenal crisis increase with age greater than 60 years. [13]
Race
- There is no racial predilection to adrenal insufficiency. [14]
Gender
- Females are more commonly affected by adrenal insufficiency than males. The female to male ratio is approximately 2 to 1 for primary adrenal insufficiency. [15]
- Acute adrenal crisis affects males and females equally. [16]
Region
- The highest incidence of adrenal insufficiency has been reported in Iceland.[17]
Developed Countries
Worldwide, the most common cause of primary adrenal insufficiency was Tuberculosis. However, since the 1950s the incidence of autoimmune adrenalitis has been rising. Now, the most common cause of primary adrenal insufficiency in the developed world is autoimmune adrenalitis. [18]
Developing Countries
The most common cause of primary adrenal insufficiency in the developing world is Tuberculosis. [19]
References
- ↑ Melmed, Shlomo (2020). Williams textbook of endocrinology. Philadelphia, PA: Elsevier. ISBN 9780323555968.
- ↑ Elshimy G, Alghoula F, Jeong JM. PMID 29763143. Missing or empty
|title=(help) - ↑ Melmed, Shlomo (2020). Williams textbook of endocrinology. Philadelphia, PA: Elsevier. ISBN 9780323555968.
- ↑ Laureti S, Vecchi L, Santeusanio F, Falorni A (May 1999). “Is the prevalence of Addison’s disease underestimated?”. J Clin Endocrinol Metab. 84 (5): 1762. doi:10.1210/jcem.84.5.5677-7. PMID 10323417.
- ↑ Erichsen MM, Løvås K, Skinningsrud B, Wolff AB, Undlien DE, Svartberg J, Fougner KJ, Berg TJ, Bollerslev J, Mella B, Carlson JA, Erlich H, Husebye ES (December 2009). “Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry”. J Clin Endocrinol Metab. 94 (12): 4882–90. doi:10.1210/jc.2009-1368. PMID 19858318.
- ↑ Olafsson AS, Sigurjonsdottir HA (January 2016). “INCREASING PREVALENCE OF ADDISON DISEASE: RESULTS FROM A NATIONWIDE STUDY”. Endocr Pract. 22 (1): 30–5. doi:10.4158/EP15754.OR. PMID 26437215.
- ↑ “Group 1. Epidemiology of primary and secondary adrenal insufficiency: Prevalence and incidence, acute adrenal insufficiency, long-term morbidity and mortality – ScienceDirect”.
- ↑ “Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain – Regal – 2001 – Clinical Endocrinology – Wiley Online Library”.
- ↑ Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC, Stewart PM (February 2001). “Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group”. Lancet. 357 (9254): 425–31. doi:10.1016/s0140-6736(00)04006-x. PMID 11273062.
- ↑ Elshimy G, Alghoula F, Jeong JM. PMID 29763143. Missing or empty
|title=(help) - ↑ Øksnes M, Husebye ES (December 2023). “Approach to the Patient: Diagnosis of Primary Adrenal Insufficiency in Adults”. J Clin Endocrinol Metab. 109 (1): 269–278. doi:10.1210/clinem/dgad402. PMC 10735307 Check
|pmc=value (help). PMID 37450570 Check|pmid=value (help). - ↑ Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dungan K, Grossman A, Hershman JM, Hofland HJ, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Purnell J, Singer F, Stratakis CA, Trence DL, Wilson DP, Nicolaides NC, Chrousos GP, Charmandari E. PMID 25905309. Missing or empty
|title=(help) - ↑ Elshimy G, Alghoula F, Jeong JM. PMID 29763143. Missing or empty
|title=(help) - ↑ Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dungan K, Grossman A, Hershman JM, Hofland HJ, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Purnell J, Singer F, Stratakis CA, Trence DL, Wilson DP, Nicolaides NC, Chrousos GP, Charmandari E. PMID 25905309. Missing or empty
|title=(help) - ↑ Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dungan K, Grossman A, Hershman JM, Hofland HJ, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Purnell J, Singer F, Stratakis CA, Trence DL, Wilson DP, Nicolaides NC, Chrousos GP, Charmandari E. PMID 25905309. Missing or empty
|title=(help) - ↑ Elshimy G, Alghoula F, Jeong JM. PMID 29763143. Missing or empty
|title=(help) - ↑ Elshimy G, Alghoula F, Jeong JM. PMID 29763143. Missing or empty
|title=(help) - ↑ Gardner, David (2018). Greenspan’s basic & clinical endocrinology. New York, N.Y: McGraw-Hill Education LLC. ISBN 9781259589287.
- ↑ Gardner, David (2018). Greenspan’s basic & clinical endocrinology. New York, N.Y: McGraw-Hill Education LLC. ISBN 9781259589287.
Risk factors
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayeesha Kattubadi, M.B.B.S[2]
Overview
Common risk factors in the development of adrenal insufficiency include chronic glucocorticoid use, tuberculosis, anticoagulant use, etc.
Risk Factors
Common risk factors in the development of chronic adrenal insufficiency include patients on chronic glucocorticoids , anticoagulants, tuberculosis, adrenal gland surgery, presence of other autoimmune conditions like Type 1 diabetes mellitus.
Following is the table showing the risk factors associated with increased risk of developing acute adrenal crisis [1].
| Risk factors associated with increased risk of adrenal crisis | ||
|---|---|---|
| History | Drugs | Medical conditions |
|
|
|
References
Screening
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayeesha Kattubadi, M.B.B.S[2] Muhammad Saad, M.B.B.S.[3]
Overview
There is insufficient evidence to recommend routine screening for adrenal insufficiency. Newborn screening for congenital adrenal hyperplasia is recommended.
Screening
There is insufficient evidence to recommend routine screening for adrenal insufficiency. [1]The most common causes of primary adrenal insufficiency are autoimmune adrenalitis and congenital adrenal hyperplasia due to 21-Hydroxylase deficiency. Screening is recommended in childern suspected of developing congenital adrenal hyperplasia.[2]
References
- ↑ Chanson, Philippe; Guignat, Laurence; Goichot, Bernard; Chabre, Olivier; Boustani, Dinane Samara; Reynaud, Rachel; Simon, Dominique; Tabarin, Antoine; Gruson, Damien; Reznik, Yves; Raffin Sanson, Marie-Laure (2017). “Group 2: Adrenal insufficiency: screening methods and confirmation of diagnosis”. Annales d’Endocrinologie. 78 (6): 495–511. doi:10.1016/j.ando.2017.10.005. ISSN 0003-4266.
- ↑ Therrell BL (March 2001). “Newborn screening for congenital adrenal hyperplasia”. Endocrinol Metab Clin North Am. 30 (1): 15–30. doi:10.1016/s0889-8529(08)70017-3. PMID 11344933.
Natural History, Complications and Prognosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayeesha Kattubadi, M.B.B.S[2] Muhammad Saad, M.B.B.S.[3]
Overview
Common complications of adrenal insufficiency include cardiovascular complications, disturbed sleep, reduced bone mineral density. Prognosis is generally excellent with replacement therapy.
Natural History, Complications, and Prognosis
Natural History
- The symptoms of adrenal insufficiency usually develop in the third to fifth decade of life, and start with symptoms such as fatigue, anorexia, weight loss, nausea, abdominal pain.
- If left untreated, chronic adrenal insufficiency in the presence of precipitating factors can develop adrenal crisis presenting with acute hemodynamic compromise. [1]
- Up to half of patients with primary adrenal insufficiency may experience adrenal crisis prior to diagnosis. [2]
Complications
- Common complications of adrenal insufficiency include: [3]
- Increased risk of cardiovascular complications.
- Sleep disturbance due to disruption of circadian rhythm.
- Decreased bone mineral density as a consequence of glucocorticoid therapy.
- Fertility and pregnancy complications: Reduced fertility, increased risk of fetal growth restriction, preterm birth, cesarean delivery
Prognosis
- Prognosis is generally excellent with replacement therapy and patients are able to work, travel and participate in sports[4] [5].
- Depending on the age of the diagnosis of adrenal insufficiency the prognosis may vary. If the patient is diagnosed before the age of 40, there is increased mortality.
- Mortality is increased in patients presenting with acute adrenal crisis, infection, or associated with type 1 diabetes mellitus [6].
- Patients with glucocorticoid-induced adrenal insufficiency may recover hypothalamic-pituitary-adrenal axis function over months to years after discontinuation of glucocorticoids [2].
References
- ↑ Pazderska, Agnieszka; Pearce, Simon HS (2017). “Adrenal insufficiency – recognition and management”. Clinical Medicine. 17 (3): 258–262. doi:10.7861/clinmedicine.17-3-258. ISSN 1470-2118.
- ↑ 2.0 2.1 “Adrenal Insufficiency in Adults: A Review | Endocrinology | JAMA | JAMA Network”.
- ↑ “www.amjmed.com”.
- ↑ Li D, Brand S, Hamidi O, Westfall AA, Suresh M, Else T, Vaidya A, Bancos I (June 2022). “Quality of Life and its Determinants in Patients With Adrenal Insufficiency: A Survey Study at 3 Centers in the United States”. J Clin Endocrinol Metab. 107 (7): e2851–e2861. doi:10.1210/clinem/dgac175. PMC 9202727 Check
|pmc=value (help). PMID 35350067 Check|pmid=value (help). - ↑ Li D, Genere N, Behnken E, Xhikola M, Abbondanza T, Vaidya A, Bancos I (March 2021). “Determinants of Self-reported Health Outcomes in Adrenal Insufficiency: A Multisite Survey Study”. J Clin Endocrinol Metab. 106 (3): e1408–e1419. doi:10.1210/clinem/dgaa668. PMC 7947833 Check
|pmc=value (help). PMID 32995875 Check|pmid=value (help). - ↑ Erichsen, Martina M; Løvås, Kristian; Fougner, Kristian J; Svartberg, Johan; Hauge, Erik R; Bollerslev, Jens; Berg, Jens P; Mella, Bjarne; Husebye, Eystein S (2009). “Normal overall mortality rate in Addison’s disease, but young patients are at risk of premature death”. European Journal of Endocrinology. 160 (2): 233–237. doi:10.1530/EJE-08-0550. ISSN 0804-4643.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
